The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
27
No.
35
September 28, 2001
- Reorganization, Money Will Cure Cancer In 21st Century, NCLAC Report Promises.
- Three Geneticists Of “Knockout” Mice Fame Win Lasker Award For Basic Research.
- Caryn Lerman Recruited By Univ. Of Pennsylvania.
- BMS, ImClone To Develop New Drug IMC-C225, Targets EGF Receptor.
- FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.
- Impath Buys Clinical Studies Support Services Network.
- MGI Pharma, MethylGene Begin Phase II Trial Of MG98.
- Vasopermeation Technology Awarded Patent For CA Firm.
- FDA Approves Xeloda For Breast Cancer Treatment.
TCL
Vol.
27
No.
36
October 05, 2001
- Practice Management Giant US Oncology To Sell Practices Back to Physicians.
- Alan Rabson Named Acting NCI Director
- HHS Pick For FDA May Be Food Safety Expert.
- Fisher To Direct Wilmot CC
- Case Western Wins Renewal.
- House Panel Targets AWP For Medicare Drug Pricing.
- From Long Island To Houston By Rental Care, In 43 Hours.
TCL
Vol.
27
No.
37
October 12, 2001
- NCI Asks Centers To Limit Increases In Applying For Support Grant Renewals.
- Cancer Researchers Share 2001 Nobel Prize For Cell Cycle, Chromosome Discoveries.
- NCI Management Director Leaving For Case Institute.
- Avon Awards $50 Million To NCI And Three Centers.
- NIAID, Vaccine Center Begin Phase I Trial Of AIDS Vaccine.
- Number Of Uninsured To Increase, Report Finds.
TCL
Vol.
27
No.
38
October 19, 2001
- Feinstein Slams Cancer Act Proposal, Calls White Paper Vague And Unrealistic.
- Mark Israel To Direct Norris Cotton Center
- Foundation For COG Is New Name Of NCCF.
- ACCC Honors Hammond, Murphy
- Moses To Lead AACI.
- AHRQ Funds Research To Reduce Medical Errors.
- The Cancer Letter Provides Full Text Of Publications To University Of Kentucky.
TCL
Vol.
27
No.
39
October 26, 2001
- House Approves NCI’s First $4 Billion Budget, $22.8 Billion For NIH In FY2002.
- Foundation Honors Three In Oncology; Society Wins Software Grant From Microsoft.
- Arthur James, Ohio Founder Of Research Institute, Dead.
- Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.
- Genitope Therapy In Phase III Trials For Low-Grade B-Cell Non-Hodgkin’s.
- Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.
CCL
Vol.
24
No.
10
October 26, 2001
- Advanced Ovarian Cancer Responds To Irofulven In Phase II Studies
- Older Colon Cancer Patients Also Benefit From Chemotherapy, NCCTG Study Finds
- Rare Lung Disease Raises Risk Of Meningiomas
- Study Tracks Lifestyle Factors For Cancer Burden In Blacks
- Breast Removal Reduces Risk Of Cancer In BRCA Carriers
- Study Underway To Help Childhood Cancer Survivors With Learning Difficulties
- Protocols Approved During The Month of September 2001